Article category

  • HOME
  • ARTICLE CATEGORY
  • Article category
Editorial
Drug-drug interactions with direct-acting antivirals — less is more
Grace Lai-Hung Wong
Clin Mol Hepatol. 2021;27(1):81-82.   Published online December 3, 2020
View: 3521   Download: 99  Web of Science: 1  Crossref: 1
Review
1579
The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
Yusuke Watanabe, Atsunori Tsuchiya, Shuji Terai
Clin Mol Hepatol. 2021;27(1):70-80.   Published online December 3, 2020
View: 11496   Download: 391  Web of Science: 61  Crossref: 63
1569
Recent updates on the management of autoimmune hepatitis
Atsumasa Komori
Clin Mol Hepatol. 2021;27(1):58-69.   Published online December 10, 2020
View: 13929   Download: 1,103  Web of Science: 55  Crossref: 66
1568
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
Erica Jennison, Christopher D. Byrne
Clin Mol Hepatol. 2021;27(1):22-43.   Published online December 10, 2020
View: 8832   Download: 414  Web of Science: 41  Crossref: 44
1566
Current understanding of primary biliary cholangitis
Atsushi Tanaka
Clin Mol Hepatol. 2021;27(1):1-21.   Published online December 3, 2020
View: 12579   Download: 778  Web of Science: 50  Crossref: 58
Special topic: Alcoholic liver diseases
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)
Hepatic Hippo signaling inhibits development of hepatocellular carcinoma
Yuchen Liu, Xiaohui Wang, Yingzi Yang
Clin Mol Hepatol. 2020;26(4):742-750.   Published online September 28, 2020
View: 7255   Download: 198  Web of Science: 35  Crossref: 33
Alcohol and hepatocarcinogenesis
Makiko Taniai
Clin Mol Hepatol. 2020;26(4):736-741.   Published online October 1, 2020
View: 5926   Download: 172  Web of Science: 21  Crossref: 18
Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights
Kenichi Ikejima, Kazuyoshi Kon, Shunhei Yamashina
Clin Mol Hepatol. 2020;26(4):728-735.   Published online October 1, 2020
View: 6020   Download: 182  Web of Science: 26  Crossref: 26
Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases
Yun Seok Kim, Sang Geon Kim
Clin Mol Hepatol. 2020;26(4):715-727.   Published online September 22, 2020
View: 8710   Download: 255  Web of Science: 29  Crossref: 29
Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease
Sen Han, Ting Zhang, Praveen Kusumanchi, Nazmul Huda, Yanchao Jiang, Zhihong Yang, Suthat Liangpunsakul
Clin Mol Hepatol. 2020;26(4):705-714.   Published online October 1, 2020
View: 4286   Download: 86  Web of Science: 8  Crossref: 9
Oxidative stress and glutamate excretion in alcoholic steatosis: Metabolic synapse between hepatocyte and stellate cell
Hee-Hoon Kim, Sung Eun Choi, Won-Il Jeong
Clin Mol Hepatol. 2020;26(4):697-704.   Published online October 1, 2020
View: 5757   Download: 141  Web of Science: 8  Crossref: 7
Emerging medical therapies for severe alcoholic hepatitis
David Tornai, Gyongyi Szabo
Clin Mol Hepatol. 2020;26(4):686-696.   Published online September 28, 2020
View: 5775   Download: 214  Web of Science: 15  Crossref: 15
Roles of the complement system in alcohol-induced liver disease
Yi Zhou, Guandou Yuan, Fudi Zhong, Songqing He
Clin Mol Hepatol. 2020;26(4):677-685.   Published online October 1, 2020
View: 6321   Download: 140  Web of Science: 9  Crossref: 10
Liver-lung axes in alcohol-related liver disease
Gavin E. Arteel
Clin Mol Hepatol. 2020;26(4):670-676.   Published online October 1, 2020
View: 5322   Download: 112  Web of Science: 10  Crossref: 9
The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
Jong Hwa Choi, Won Sohn, Yong Kyun Cho
Clin Mol Hepatol. 2020;26(4):662-669.   Published online September 25, 2020
View: 8292   Download: 164  Web of Science: 32  Crossref: 32
Global and regional impacts of alcohol use on public health: Emphasis on alcohol policies
Seung Ha Park, Dong Joon Kim
Clin Mol Hepatol. 2020;26(4):652-661.   Published online October 1, 2020
View: 4847   Download: 97  Web of Science: 16  Crossref: 19
Predictors of steroid non-response and new approaches in severe alcoholic hepatitis
Shiv Kumar Sarin, Shvetank Sharma
Clin Mol Hepatol. 2020;26(4):639-651.   Published online October 1, 2020
View: 8243   Download: 239  Web of Science: 10  Crossref: 11
The lymphatic system in alcohol-associated liver disease
Reiichiro Kondo, Yasuko Iwakiri
Clin Mol Hepatol. 2020;26(4):633-638.   Published online September 21, 2020
View: 7634   Download: 141  Web of Science: 3  Crossref: 3
Inter-professional and inter-departmental alcoholism rehabilitation program
Masahiro Kikuchi, Naomi Matsutani, Ryota Ishihara, Masako Sugihara, Yuuki Mizuno, Chiyo Chiba, Takahiro Ohta, Eri Yamada, Sota Oguro, Yasuko Sato, Hiroki Bessho, Yoshinori Horie
Clin Mol Hepatol. 2020;26(4):626-632.   Published online October 1, 2020
View: 3766   Download: 65  Web of Science: 1  Crossref: 1
Programmed cell death in alcohol-associated liver disease
Tatsunori Miyata, Laura E. Nagy
Clin Mol Hepatol. 2020;26(4):618-625.   Published online September 21, 2020
View: 10290   Download: 262  Web of Science: 35  Crossref: 40
Autophagy and liver cancer
Xiaojuan Chao, Hui Qian, Shaogui Wang, Sam Fulte, Wen-Xing Ding
Clin Mol Hepatol. 2020;26(4):606-617.   Published online October 1, 2020
View: 8128   Download: 246  Web of Science: 42  Crossref: 40
From intestinal dysbiosis to alcohol-associated liver disease
Beatriz Garcia Mendes, Bernd Schnabl
Clin Mol Hepatol. 2020;26(4):595-605.   Published online September 11, 2020
View: 7643   Download: 222  Web of Science: 19  Crossref: 22
Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: A model of high-fat diet and binge ethanol intake
Seonghwan Hwang, Tianyi Ren, Bin Gao
Clin Mol Hepatol. 2020;26(4):586-594.   Published online September 17, 2020
View: 6837   Download: 203  Web of Science: 17  Crossref: 16
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)
Dong Joon Kim, Won-Il Jeong, Hidekazu Tsukamoto, Bin Gao
Clin Mol Hepatol. 2020;26(4):584-585.   Published online October 1, 2020
View: 3331   Download: 72
Letter to the Editor
Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
Dimitrios Patoulias, Michael Doumas
Clin Mol Hepatol. 2020;26(4):582-583.   Published online September 25, 2020
View: 3355   Download: 66  Web of Science: 2  Crossref: 2
Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?
Jeong Su Park, Soo Han Bae
Clin Mol Hepatol. 2020;26(4):577-578.   Published online September 17, 2020
View: 3468   Download: 64  Web of Science: 1  Crossref: 1
Original Article
Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea
Yu Rim Lee, Min Kyu Kang, Jeong Eun Song, Hyun Jung Kim, Young Oh Kweon, Won Young Tak, Se Young Jang, Jung Gil Park, Changhyeong Lee, Jae Seok Hwang, Byoung Kuk Jang, Jeong Ill Suh, Woo Jin Chung, Byung Seok Kim, Soo Young Park
Clin Mol Hepatol. 2020;26(4):562-576.   Published online October 1, 2020
View: 6223   Download: 181  Web of Science: 22  Crossref: 23
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment
Desmond Y. H. Yap, Kevin S. H. Liu, Yu-Chun Hsu, Grace L. H. Wong, Ming-Chang Tsai, Chien-Hung Chen, Ching-Sheng Hsu, Yee Tak Hui, Michael K. K. Li, Chen-Hua Liu, Yee-Man Kan, Ming-Lung Yu, Man-Fung Yuen
Clin Mol Hepatol. 2020;26(4):554-561.   Published online August 28, 2020
View: 4943   Download: 166  Web of Science: 8  Crossref: 8

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 119
TOTAL : 1736127
Close layer